Does the Approach Matter

Slides:

Advertisements

Similar presentations

Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L

Advertisements

Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes Meng S. Shao, MD, Andrew T. Wong, MD,

Lymphovascular Invasion as a Prognostic Indicator in Stage I Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis Nathan M. Mollberg, DO,

Treating Constrictive Pericarditis in a Chinese Single-Center Study: A Five-Year Experience Yiyun Lin, MD, Mi Zhou, MMS, Jian Xiao, MD, Bin Wang, MD,

Benny Weksler, MD, Jennifer L. Sullivan, MD

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Chi-Fu Jeffrey Yang, MD, Derek Y. Chan, BSE, Paul J

Emergent Esophagectomy for Esophageal Perforations: A Safe Option

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Log Odds of Positive Lymph Nodes Predicts Survival in Patients After Resection for Esophageal Cancer Jinlin Cao, MD, Ping Yuan, MD, Honghai Ma, MD, Peng.

Minimally Invasive Versus Sternotomy Approach for Mitral Valve Surgery in Patients Greater Than 70 Years Old: A Propensity-Matched Comparison David M.

Salvage Resections for Recurrent or Persistent Cancer of the Proximal Esophagus After Chemoradiotherapy Colin Schieman, MD, Dennis A. Wigle, MD, PhD,

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Prognostic Value of Different Lymph Node Staging Methods in Esophageal Squamous Cell Carcinoma After Esophagectomy San-Gang Wu, MD, Feng-Yan Li, MD,

A Model to Predict the Use of Surgical Resection for Advanced-Stage Non-Small Cell Lung Cancer Patients Elizabeth A. David, MD, Stina W. Andersen, PhD,

Gal Levy, MD, Mark A. Cordes, MD, Alexander S. Farivar, MD, Ralph W

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Clinical T2N0 Esophageal Cancer: Identifying Pretreatment Characteristics Associated With Pathologic Upstaging and the Potential Role for Induction Therapy

Lobectomy in Octogenarians With Non-Small Cell Lung Cancer: Ramifications of Increasing Life Expectancy and the Benefits of Minimally Invasive Surgery

Outcomes, quality of life, and survival after esophagectomy for squamous cell carcinoma: A propensity score–matched comparison of operative approaches

Induction Chemotherapy is Not Superior to a Surgery-First Strategy for Clinical N1 Non- Small Cell Lung Cancer Paul J. Speicher, MD, Zachary W. Fitch,

Castigliano M. Bhamidipati, DO, MS, George J

Prognostic Variables in Thoracic Esophageal Squamous Cell Carcinoma

David T. Cooke, MD, Danh V. Nguyen, PhD, Ying Yang, MS, Steven L

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer Robert E. Merritt, MD, Chuong D. Hoang, MD,

Loretta Erhunmwunsee, MD, Brian C

Adding Radiotherapy to Adjuvant Chemotherapy Does Not Improve Survival of Patients With N2 Lung Cancer Justin A. Drake, MD, David C. Portnoy, MD, Kurt.

Linda Henry, PhD, RN, Linda Halpin, MSN, RN, Sharon Hunt, MBA, Sari D

Minimally Invasive Versus Open Esophagectomy for Esophageal Cancer: A Population- Based Analysis Babatunde A. Yerokun, MD, Zhifei Sun, MD, Chi-Fu Jeffrey.

Readmission to Intensive Care Unit After Initial Recovery From Major Thoracic Oncology Surgery Suk-Won Song, MD, Hyun-Sung Lee, MD, PhD, Jae-Hyun Kim,

Robotic Thymectomy in Anterior Mediastinal Mass: Propensity Score Matching Study With Transsternal Thymectomy Chang Hyun Kang, MD, PhD, Yoohwa Hwang,

Adjuvant Chemotherapy Is Associated With Improved Survival in Locally Invasive Node Negative Non-Small Cell Lung Cancer Usman Ahmad, MD, Traves D. Crabtree,

Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R

Who Do You Say You Are? The Annals of Thoracic Surgery

Surgical Considerations for the Management and Resection of Esophageal Gastrointestinal Stromal Tumors Matthew G. Blum, MD, Karl Y. Bilimoria, MD, Jeffrey.

Percutaneous Intervention Before Coronary Artery Bypass Surgery Does Not Unfavorably Impact Survival: A Single-Center Propensity-Matched Analysis Suvitesh.

Impact of Lepidic Component Occupancy on Effects of Adjuvant Chemotherapy for Lung Adenocarcinoma Shinsuke Sasada, MD, PhD, Yoshihiro Miyata, MD, PhD,

Quality Measures in Clinical Stage I Non-Small Cell Lung Cancer: Improved Performance Is Associated With Improved Survival Pamela Samson, MD, MPHS, Traves.

Age-Dependent Gender Disparities in Post Lung Transplant Survival Among Patients With Idiopathic Pulmonary Fibrosis Shahid I. Sheikh, MD, Don Hayes,

Radical Lymph Node Dissection in Primary Esophagectomy for Esophageal Squamous Cell Carcinoma Chen-Sung Lin, MD, PhD, Chih-Tao Cheng, MD, DrPH, Chao-Yu.

Use of Amiodarone After Major Lung Resection

Elliot Wakeam, MD, MPH, James P. Byrne, MD, Gail E

Number of Lymph Nodes Associated With Maximal Reduction of Long-Term Mortality Risk in Pathologic Node-Negative Non–Small Cell Lung Cancer Raymond U.

Jaimin R. Trivedi, MD, MPH, Allen Cheng, MD, Michele Gallo, MD, Erin M

Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer Lisa M. Brown, MD, Brian.

Is There a Role for Cancer-Directed Surgery in Early-Stage Sarcomatoid or Biphasic Mesothelioma? Samuel Kim, MD, David A. Bull, MD, Linda Garland, MD,

Andrew P. Dhanasopon, MD, Michelle C. Salazar, MD, Jessica R

Predictors of Long-Term Survival After Resection of Esophageal Carcinoma With Nonregional Nodal Metastases Paul C. Lee, MD, Jeffrey L. Port, MD, Subroto.

Nodal Skip Metastasis in Esophageal Squamous Cell Carcinoma Patients Undergoing Three-Field Lymphadenectomy Feng Wang, MD, Yuzhen Zheng, MD, Zhen Wang,

Heterogeneity of Tumor Sizes in Multiple Pulmonary Metastases of Colorectal Cancer as a Prognostic Factor Tomohiro Maniwa, MD, Keita Mori, PhD, Yasuhisa.

High Expression of p300 Has an Unfavorable Impact on Survival in Resectable Esophageal Squamous Cell Carcinoma Yong Li, MD, Hao-Xian Yang, MD, Rong-Zhen.

Sublobar Resection Provides an Equivalent Survival After Lobectomy in Elderly Patients With Early Lung Cancer Jiro Okami, MD, PhD, Yuri Ito, PhD, Masahiko.

Characteristics of Malignant Pleural Mesothelioma in Women

Clinicopathologic Features of Submucosal Esophageal Squamous Cell Carcinoma Manabu Emi, MD, PhD, Jun Hihara, MD, PhD, Yoichi Hamai, MD, PhD, Takaoki Furukawa,

Posttransplant Outcomes Among Septuagenarians Bridged to Transplantation With Continuous-Flow Left Ventricular Assist Devices Shinichi Fukuhara, MD,

Surgical Outcomes of Chronic Descending Dissections: Type I Versus III DeBakey Ivancarmine Gambardella, MD, FRCS, Mario Gaudino, MD, Christopher Lau,

Risk Factors for Local Recurrence and Optimal Length of Esophagectomy in Esophageal Squamous Cell Carcinoma Chang Hyun Kang, MD, PhD, Yoohwa Hwang, MD,

Specialty Training and Mortality After Esophageal Cancer Resection

Adhering to Quality Measures in Esophagectomy Is Associated With Improved Survival in All Stages of Esophageal Cancer Pamela Samson, MD, MPHS, Varun.

Transthoracic Esophagectomy Using Endobronchial Blocker After Previous Pneumonectomy Haifeng Wang, MD, Ji Liu, MD, Chao Jiang, MD, Ming Liu, MD, Gening.

Is There a Benefit to Prolonging the Interval Between Neoadjuvant Chemoradiation and Esophagectomy in Esophageal Cancer? Anna Lee, MD, MPH, Andrew T.

Effects of Delayed Surgical Resection on Short-Term and Long-Term Outcomes in Clinical Stage I Non-Small Cell Lung Cancer Pamela Samson, MD, Aalok Patel,

Luis F. Tapias, MD, Douglas J. Mathisen, MD, Cameron D

Neal S Goldstein, MD The Annals of Thoracic Surgery

Survival Benefits of Postoperative Chemoradiation for Lymph Node–Positive Esophageal Squamous Cell Carcinoma Po-Kuei Hsu, MD, Chien-Sheng Huang, MD,

The Society of Thoracic Surgeons Composite Score for Rating Program Performance for Lobectomy for Lung Cancer Benjamin D. Kozower, MD, MPH, Sean M. O’Brien,

Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study Robert J. Cerfolio, MD, Ayesha.

Lobectomy Versus Limited Resection in T1N0 Lung Cancer

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Induction Chemoradiation Is Not Superior to Induction Chemotherapy Alone in Stage IIIA Lung Cancer Asad A. Shah, MD, Mark F. Berry, MD, Ching Tzao, MD,

Presentation transcript:

Does the Approach Matter Does the Approach Matter? Comparing Survival in Robotic, Minimally Invasive, and Open Esophagectomies Fernando Espinoza-Mercado, MD, Taryne A. Imai, MD, Jerald D. Borgella, MD, Ariella Sarkissian, HSDG, Derek Serna-Gallegos, MD, Rodrigo F. Alban, MD, Harmik J. Soukiasian, MD The Annals of Thoracic Surgery Volume 107, Issue 2, Pages 378-385 (February 2019) DOI: 10.1016/j.athoracsur.2018.08.039 Copyright © 2019 The Society of Thoracic Surgeons Terms and Conditions

The Annals of Thoracic Surgery 2019 107, 378-385DOI: (10. 1016/j The Annals of Thoracic Surgery 2019 107, 378-385DOI: (10.1016/j.athoracsur.2018.08.039) Copyright © 2019 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 CONSORT (Consolidated Standards of Reporting Trials) diagram for esophageal cancer patient selection. (MIE = minimally invasive esophagectomy; NCDB = National Cancer Database; OE = open esophagectomy; PUF = participant user file; RAMIE = robotic-assisted minimally invasive esophagectomy; SQCC = squamous cell carcinoma.) The Annals of Thoracic Surgery 2019 107, 378-385DOI: (10.1016/j.athoracsur.2018.08.039) Copyright © 2019 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Esophagectomy trends for resectable middle- and lower-third esophageal cancer, National Cancer Database 2010 to 2015. (MIE = minimally invasive esophagectomy; OE = open esophagectomy; RAMIE = robotic-assisted minimally invasive esophagectomy.) The Annals of Thoracic Surgery 2019 107, 378-385DOI: (10.1016/j.athoracsur.2018.08.039) Copyright © 2019 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Survival curves after propensity score matching: minimally invasive esophagectomy (MIE) versus open esophagectomy (OE), robotic-assisted minimally invasive esophagectomy (RAMIE) versus OE, and MIE versus RAMIE. (CI = confidence interval; cum = cumulative; Dx = diagnosis; HR = hazard ratio.) The Annals of Thoracic Surgery 2019 107, 378-385DOI: (10.1016/j.athoracsur.2018.08.039) Copyright © 2019 The Society of Thoracic Surgeons Terms and Conditions